November 04, 2024

HSP's visit to São Paulo

On October 22, HSP had the opportunity to visit São Paulo’s Butantan Institute and the Pasteur Institute of São Paulo. The tour offered insight into Brazil's key research and production sites, featuring an in-depth visit to Butantan’s biosafety level-3 production facility, where preparations are underway to launch a facility dedicated to producing a single-dose dengue vaccine, anticipated for commissioning in 2025. This development could mark a major step forward in dengue prevention both in Brazil and globally, as recent studies show the vaccine protects 79.6% of those vaccinated*. Many thanks to the teams at both institutes for an insightful look into these essential advancements in public health, as well as to the U.S. Department of State - Bureau of International Security and Nonproliferation for supporting this initiative. * https://www.nejm.org/doi/full/10.1056/NEJMoa2301790?query=featured_home